Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models.
PLoS One. 2020 Sep 24;15(9):e0239595. doi: 10.1371/journal.pone.0239595. eCollection 2020.
PLoS One. 2020.
PMID: 32970735
Free PMC article.
Persistent antigen exposure via the eryptotic pathway drives terminal T cell dysfunction.
Watkins EA, Antane JT, Roberts JL, Lorentz KM, Zuerndorfer S, Dunaif AC, Bailey LJ, Tremain AC, Nguyen M, De Loera RC, Wallace RP, Weathered RK, Kontos S, Hubbell JA.
Watkins EA, et al. Among authors: zuerndorfer s.
Sci Immunol. 2021 Feb 26;6(56):eabe1801. doi: 10.1126/sciimmunol.abe1801.
Sci Immunol. 2021.
PMID: 33637595
Item in Clipboard
Cite
Cite